Share This Page
Suppliers and packagers for gentak
✉ Email this page to a colleague
gentak
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Pharmobedient | GENTAK | gentamicin sulfate | SOLUTION/DROPS;OPHTHALMIC | 064163 | ANDA | Proficient Rx LP | 63187-764-05 | 1 BOTTLE, DROPPER in 1 CARTON (63187-764-05) / 5 mL in 1 BOTTLE, DROPPER | 2006-12-13 |
| Pharmobedient | GENTAK | gentamicin sulfate | SOLUTION/DROPS;OPHTHALMIC | 064163 | ANDA | NuCare Pharmaceuticals, Inc. | 66267-971-05 | 1 BOTTLE, DROPPER in 1 CARTON (66267-971-05) / 5 mL in 1 BOTTLE, DROPPER | 2006-12-13 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: GENTAK (Gentamicin)
Introduction
GENTAK (gentamicin sulfate) is a broad-spectrum aminoglycoside antibiotic used primarily to treat serious bacterial infections. It is particularly effective against Gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, and Klebsiella species. Due to its critical role in combating life-threatening infections, a reliable supply chain of GENTAK is vital for healthcare providers globally. This article examines the key suppliers, manufacturing landscape, sourcing considerations, and market dynamics relevant to GENTAK, facilitating informed decision-making for stakeholders in the pharmaceutical supply chain.
Overview of GENTAK Production and Supply Chain
GENTAK's active pharmaceutical ingredient (API), gentamicin sulfate, is produced via complex fermentation processes involving microbial bio-reactions primarily with Micromonospora species. Following synthesis, the API undergoes multiple purification steps before formulation into injectable solutions or topical forms. The entire supply chain encompasses API manufacturing, formulation, packaging, and distribution. Several large pharmaceutical companies and specialized contract manufacturers dominate the production landscape for GENTAK, reflecting high regulatory standards and quality requirements.
Major Suppliers and Manufacturers of GENTAK
1. Local and International Pharmaceutical Companies
a. Pfizer Inc.
Pfizer’s production of gentamicin is among the most recognized globally. Historically, Pfizer has been a pivotal player in the antibiotic market, maintaining manufacturing facilities capable of supplying large volumes of GENTAK. The company's global distribution network ensures broad availability across markets, supported by their robust R&D pipeline and stringent quality controls. Pfizer's longstanding presence in the antibiotic segment signifies reliability and regulatory compliance in the supply chain [1].
b. Hikma Pharmaceuticals
Hikma is a prominent manufacturer of generic antibiotics, including gentamicin sulfate. The company operates manufacturing plants in Jordan and Europe, with a focus on high-quality injectable antibiotics. Hikma's generic antibiotic portfolio, including GENTAK, benefits from ISO standards compliance, WHO prequalification, and rigorous regulatory oversight, ensuring supply stability for developing markets [2].
c. Fresenius Kabi
Fresenius Kabi specializes in sterile preparations and parenteral medicines. Their global manufacturing facilities produce gentamicin sulfate solutions, adhering to internationally recognized quality standards like GMP (Good Manufacturing Practice). Fresenius Kabi's strategic manufacturing centers across Europe, Asia, and North America enable large-volume production with reliable supply chains.
d. Sandoz (Novartis)
Sandoz, the generics division of Novartis, produces gentamicin formulations distributed across multiple markets. Their extensive manufacturing capacity and adherence to regulatory standards position them as a key supplier in both developed and emerging markets.
2. Contract Manufacturing Organizations (CMOs) and APIs Suppliers
Many pharmaceutical companies rely on CMOs for the production of gentamicin sulfate API to optimize costs and manufacturing flexibility. Notably:
-
Chinese API Manufacturers:
Chinese pharmaceutical companies such as Zhejiang Medicine Co., Ltd., and Huishi Pharmaceutical produce gentamicin for both export and domestic markets. Chinese API manufacturers have become significant contributors owing to cost competitiveness and expanding capacity, although quality assurance and regulatory compliance (e.g., FDA, EMA approvals) are critical selection criteria [3]. -
Indian API Manufacturers:
Indian firms like Sun Pharmaceutical Industries and Wockhardt manufacture gentamicin sulfate API, supplying global markets. Indian API producers benefit from advanced fermentation technology, lower costs, and compliance with international quality standards.
3. Distributors and Importers
Aside from direct manufacturers, several distributors facilitate the global supply of GENTAK. Companies such as McKesson, Cardinal Health, and local pharmaceutical distributors in various countries play pivotal roles in ensuring availability, especially in resource-limited settings.
Sources for GENTAK API and Formulations
Supply sources for GENTAK can be categorized based on geography and manufacturer specialization:
-
North America and Europe:
Suppliers like Pfizer, Fresenius Kabi, and Sandoz dominate sourcing, often with stringent regulatory approvals (FDA, EMA, PMDA). These regions prioritize high-quality standards, making these suppliers preferred for hospital procurement and regulatory compliance. -
Asia (China and India):
Numerous API manufacturers and formulators operate in these markets, offering cost-effective options. However, buyers must verify regulatory approvals and manufacturing quality through certifications such as WHO prequalification, GAC (Good Automated Control), and GMP compliance. -
Emerging Markets:
Regulators often accept APIs from certified Chinese or Indian manufacturers, subject to import and quality assessments. Local generic companies often blend imported API into proprietary formulations.
Regulatory and Quality Considerations
The pharmaceutical industry emphasizes strict regulatory oversight:
-
FDA and EMA Approvals:
Manufacturers aiming for access to North American and European markets must meet rigorous cGMP standards, with ongoing audits and approvals. -
WHO Prequalification:
For suppliers targeting low- and middle-income countries, WHO prequalification certifies compliance with international standards, facilitating procurement by United Nations agencies. -
Quality Certifications:
ISO 9001, ISO 13485, and other quality management certifications bolster supplier credibility.
Market Dynamics and Trends
-
Patent Expiry and Generics Growth:
As patents for GENTAK and other gentamicin formulations have expired, the market predominantly consists of generics. This has increased the number of suppliers but also intensified price competition. -
Manufacturing Capacity Expansion:
Increased demand from hospitals and governments has prompted significant expansion of manufacturing capacities, especially in China and India. -
Supply Chain Disruptions:
Global events like the COVID-19 pandemic disrupted supply chains for APIs and finished products, emphasizing the importance of diversified sourcing and local production capabilities. -
Regulatory Stringency:
Countries are enforcing stricter standards, necessitating suppliers to pursue international certifications to access major markets effectively.
Key Factors for Selecting GENTAK Suppliers
- Regulatory compliance (FDA, EMA, WHO prequalification)
- Manufacturing capacity and scalability
- Quality assurance and certifications
- Cost competitiveness
- Supply chain reliability and lead times
- Track record for consistency and product purity
Conclusion
The supply landscape for GENTAK encompasses a diverse spectrum of global players, including major pharmaceutical companies, Asian API manufacturers, and regional distributors. Ensuring a reliable and regulatory-compliant supply involves assessing factors such as manufacturing quality, certifications, capacity, and geopolitical stability. As the market evolves, especially with growth in generic manufacturing and regional regulations, procurement strategies must prioritize supplier credibility and diversification to mitigate supply risks.
Key Takeaways
- Major suppliers of GENTAK include Pfizer, Hikma Pharmaceuticals, Fresenius Kabi, and Sandoz, each emphasizing high regulatory and quality standards.
- API production is increasingly sourced from Chinese and Indian manufacturers, offering cost advantages but requiring rigorous quality verification.
- Regulatory compliance (FDA, EMA, WHO prequalification) remains critical for supplier credibility in global markets.
- Supply chain resilience benefits from supplier diversification, especially considering recent disruptions.
- Market trends favor increased manufacturing capacity for generics, but quality assurance continues to be paramount.
FAQs
1. Who are the primary global manufacturers of GENTAK?
Pfizer, Hikma Pharmaceuticals, Fresenius Kabi, and Sandoz lead in producing both gentamicin API and finished formulations, with manufacturing facilities across North America, Europe, Asia, and the Middle East.
2. Are Chinese and Indian API producers suitable suppliers for GENTAK?
Yes. Many Chinese and Indian API manufacturers provide high-quality gentamicin sulfate, especially those with WHO prequalification and cGMP certifications. Buyers should verify specific regulatory approvals before procurement.
3. How does regulatory approval influence supplier selection?
Regulatory approvals like FDA, EMA, and WHO prequalification ensure supplier compliance with international quality standards. They are essential for access to developed markets and mitigate supply risks.
4. What factors affect the reliability of GENTAK supply chains?
Manufacturing capacity, quality certifications, regulatory compliance, geopolitical stability, and diversified sourcing strategies directly impact supply chain reliability.
5. How is market competition affecting GENTAK pricing?
Patent expirations and an influx of generic manufacturers have increased competition, leading to price reductions. However, quality and regulatory compliance often sustain premium pricing for high-standard suppliers.
Sources:
[1] Pfizer Annual Reports, 2022.
[2] Hikma Pharmaceuticals Official Website.
[3] World Health Organization (WHO) Prequalification Database.
More… ↓
